Clinical Trials Browser

Phase 2 × INDUSTRY × OGX-011 × Clear all

NCT00327340 2012-10-05

Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC

Phase 2 Completed

70 enrolled 11 charts

Prostatic Neoplasms